BioCentury | Sep 10, 2020
Finance

Sept. 9 Quick Takes: OncoImmune, Inversago raise B rounds; plus Trillium-Pfizer, Biofourmis, LinkDoc, Singleron, Hrain, InxMed and MilleporeSigma

...RMB130M series A+InxMed Co. Ltd. raised RMB130 million in a series A+ round led by Ennovation Ventures...
BioCentury | Jul 23, 2020
Deals

July 22 Quick Takes: BioNTech raises $512M; plus Vesigen, Quantro, Cullinan, TransThera, JW-Syracuse, AnHeart-NewG

...an undisclosed amount led by SDIC. Also participating were Oceanpine, SDIC Venture Capital, Summit Capital, Ennovation Ventures...
BioCentury | Apr 26, 2019
Financial News

Nanjing Leads closes series A for immuno-oncology programs

...series A round to advance its immuno-oncology programs into the clinic. Existing investors CCB Capital, Ennovation Ventures...
Items per page:
1 - 3 of 3
BioCentury | Sep 10, 2020
Finance

Sept. 9 Quick Takes: OncoImmune, Inversago raise B rounds; plus Trillium-Pfizer, Biofourmis, LinkDoc, Singleron, Hrain, InxMed and MilleporeSigma

...RMB130M series A+InxMed Co. Ltd. raised RMB130 million in a series A+ round led by Ennovation Ventures...
BioCentury | Jul 23, 2020
Deals

July 22 Quick Takes: BioNTech raises $512M; plus Vesigen, Quantro, Cullinan, TransThera, JW-Syracuse, AnHeart-NewG

...an undisclosed amount led by SDIC. Also participating were Oceanpine, SDIC Venture Capital, Summit Capital, Ennovation Ventures...
BioCentury | Apr 26, 2019
Financial News

Nanjing Leads closes series A for immuno-oncology programs

...series A round to advance its immuno-oncology programs into the clinic. Existing investors CCB Capital, Ennovation Ventures...
Items per page:
1 - 3 of 3